The FDA's advisory committee on vaccines unanimously recommended Moderna's COVID-19 vaccine for kids between the ages of 6 and 17 on Tuesday.
"I'd like to give parents as many choices as possible, and let them make the decisions about this for their children," Dr. Arthur Reingold, a committee member and the head of epidemiology at the University of California, Berkeley, said at the meeting on Tuesday.
A health worker administers a dose of a Moderna COVID-19 vaccine during a vaccination clinic at the Norristown Public Health Center in Norristown, Pa., Tuesday, Dec. 7, 2021. Moderna's vaccine has been held up over concerns that it could cause higher rates of myocarditis, or heart inflammation, than Pfizer's vaccine among young males.
Tom Shimabukuro, a member of the CDC's COVID-19 Vaccine Coordination Unit, told the advisory panel on Tuesday that "some evidence suggests that myocarditis and pericarditis risk may be higher after Moderna than after Pfizer-BioNTech," but "findings are not consistent in all U.S. monitoring systems."
The same panel will meet Wednesday to review Moderna's vaccine for children between the ages of 6 months and 6 years old.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA advisers back Moderna's COVID-19 vaccine for older kidsA government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens. The expert panel agreed Tuesday that the vaccine made by Moderna is safe and effective enough to give to U.S. kids ages 6 to 17.
Baca lebih lajut »
FDA advisers back Moderna’s COVID-19 vaccine for teens, younger kidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Baca lebih lajut »
FDA advisers to weigh expanding Covid-19 vaccines to younger childrenSeveral months after older children became eligible to get vaccinated against Covid-19, the United States might be just days away from offering vaccines to those younger than 5.
Baca lebih lajut »
FDA Advisers Considering Moderna’s Covid-19 Vaccine for Ages 6 to 17An advisory committee is set to vote Tuesday on whether to recommend that the Food and Drug Administration authorize use of the Moderna vaccine for 6- to 17-year-olds.
Baca lebih lajut »
FDA Advisers Back Moderna's COVID-19 Vaccine for Older KidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. The Food and Drug Administration’s outside experts voted unanimously that Moderna’s vaccine is safe and effective enough to give kids ages 6 to 17. If the FDA agrees, it would become the second option for those children, joining Pfizer’s vaccine. The same FDA…
Baca lebih lajut »
FDA advisers back Moderna’s COVID-19 vaccine for teens, younger kidsA government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens.
Baca lebih lajut »